Toggle navigation
Home
Search
Services
Blog
Contact
About
Macromolecular Contrast Agents for Magnetic Resonance
Hedlund, Bo Erik
Biomedical Frontiers, Inc., Minneapolis, MN, United States
Search 7 grants from Bo Hedlund
Search grants from Biomedical Frontiers, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of MicroRNAs in Tumor Progression
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers
Preventing Substance Use and Risky Behavior Among Rural African American Youth
Design and Synthesis of Gene-Specific Agents for HIR
Genetic Epidemiology of Aging and Body Composition
Recently added grants:
Feasibility and Acceptability of The Equus Effect: A Small Randomized Controlled Pilot Study of an Equine-facilitated Therapy
Ethanol & Anxiety: Cellular Mechanisms
Cellular Mechanisms in Fetal Alcohol Spectrum Disorders
Use of NMNAT chaperone activity against Alzheimer related proteinpathy.
Investigating the Contribution of Peripheral versus Central Nervous System Immune Dysfunction to Cognitive Aging
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK049367-03
Application #
2150089
Study Section
Special Emphasis Panel (ZRG7-SSS-X (14))
Project Start
1994-08-25
Project End
1996-12-31
Budget Start
1995-07-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Biomedical Frontiers, Inc.
Department
Type
DUNS #
City
Minneapolis
State
MN
Country
United States
Zip Code
55414
Related projects
NIH 1995
R44 DK
Macromolecular Contrast Agents for Magnetic Resonance
Hedlund, Bo Erik / Biomedical Frontiers, Inc.
NIH 1994
R44 DK
Macromolecular Contrast Agents for Magnetic Resonance
Hedlund, Bo Erik / Biomedical Frontiers, Inc.
Comments
Be the first to comment on this grant